Health Condition 1: M501- Cervical disc disorder with radiculopathy
Conditions
Interventions
Intervention1: HIAJAMAH BIL SHART(WET CUPPING THERAPY): 1 cup on each site of Akhdein (bony prominance behind each ear)
Control Intervention1: HIAJAMAH BIL SHART(WET CUPPING THERAPY): 1 cup will be
Sponsors
Jamia Hamdard
Eligibility
Inclusion criteria
Inclusion criteria: Patients of cervical radiculopathy in the age-group of 30-60 years. Patients of all genders. Patients with signs and symptoms of cervical spondylosis with radiculopathy; and radiological changes suggestive of the disease.(McDonald M A; Kirsch F E; et al., 2019) Cervical radiculopathy diagnosed by positive response to at least one of the four Upper Limb Tension Tests; with symptoms of cervical radiculopathy for less than 6 months. (Thoomes, et al., 2018) Pain intensity score of 30-60 mm on a 100-mm visual analog scale (VAS) Willingness to give informed consent.
Exclusion criteria
Exclusion criteria: Pregnant and lactating women. Any history of cardiac, hepatic, renal diseases. History of spinal whiplash injury / fracture. History of any spinal surgery. Patients taking NSAIDs or corticosteroids (Washout period : NSAIDs - 01 week; Corticosteroids - 6 weeks). Known cases of any other disease of cervical spine like Ankylosing spondylitis, any Vascular lesions, Neoplasms and myelopathy. Patients taking any non-pharmacological therapy for the same complaint in the past 4 weeks. (eg. Acupuncture, Hijamah, physiotherapy etc.). Patients of bleeding disorders/ anaemia (Hb � 9gm %). Patients taking Anti-coagulants. HIV/AIDS, HCV and HBsAg positive patients. Patients with uncontrolled Diabetes mellitus (HbA1C >7%) and hypertension (Systolic >129 mm Hg, Diastolic > 89 mm Hg). Alcoholic patients, tobacco users.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS (Subjective) Algometer (Objective) Jamar Dynamometer(Objective Quick-DASH Questionnaire (Subjective) SF-12 (Subjective) Cervical Range of Motion Questionnaire (Subjective) INFLAMMATORY MARKERS Tumor Necrosis Factor-ï?¡ (TNF-ï?¡) Interleukin- (IL-1Ã?²) hs-CRP Timepoint: 0 day, 42nd day and 70th day | — |
Secondary
| Measure | Time frame |
|---|---|
| CBC with ESRTimepoint: 0 day, 42nd day and 70th day | — |
Countries
India
Contacts
Public ContactYasmeen Shamsi
Jamia Hamdard
Outcome results
None listed